NewsairG is the world's leading mobile social entertainment provider, with more than 55 million unique users in more than 40 countries.airG's mobile social entertainment products and services generate billions of page impressions each month and have a proven track record of increasing customer affinity for more than 100 mobile operators including the Telefonica Group, Telstr,a Orange Group, Vodafone, AT&T and Telcel.
Outreach and information referral services to individual women & other organizations;Initiating, facilitating & participating in social justice networks & coalitions;Engaging in feminist community building. _______What's New at VSWTaller Sobre Violencia y Abuso en Contra de la MujerPara Madres Solteras Latinoamericanas de Habla HispanaFecha: Junio 26 2014 from 10am to 1pmSi eres:Mama soltera latinoamericana y hablas espan~olEstas interesada en conocer otras mamas solteras y hacer conexionesNecesitas informacio´n sobre diferentes aspectos de la violencia y abuso en contra de la mujerTe invitamos a participar en un taller en espan~ol!Lugar: 2652 E. Hastings, Vancouver, Territorio de la Costa Salish (Slocan y Hastings). Si estas interesada por favor llamanos para pre-inscribirte al 604-255-6554 con Patricia (se habla espan~ol!) para confirmar cuidado infantil.Participacio´n gratuita y abierta a mamas solteras de todas las edades con nin~os de todas las edades. Accesible en silla de ruedas, boletos de autobu´s y cuidado infantil disponible.El taller sera facilitado por Rosa Elena Arteag,a Manager of Direct Services and Clinical Practice at Battered Women Support Services (BWSS)Se servira´ refrigerio
Since its beginning in 1992, Angiotech Pharmaceuticals, Inc. has evolved from a global specialty pharmaceutical company to a medical device company and more recently to a wound closure company. During its 'specialty pharmaceutical' days Angiotech developed a differentiated R&D effort that focused on drug-medical device combinations for implantable, surgical products and acute trauma applications – this is no longer a focus of Angiotech.